Amgen's Battle with Sanofi and Regeneron at the U.S. Supreme Court over Its Cholesterol ... - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'Amgen’s battle with Sanofi and Regeneron at the U.S. Supreme Court over its cholesterol drug Repatha has some drugmakers hoping a ruling will reshape U.S. patent law and competition among companies that make antibody medicines ...'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)